Sinobiopharma, Inc. (SNBP.OB) Completes Acquisition of DongYing Pharmaceutical
Sinobiopharma, Inc., (SNBP.OB), a biotechnology company with primary operations in Nantong, China, recently announced the completed acquisition of DongYing Pharmaceutical (DongYing BVI). DongYing BVI will become a wholly-owned subsidiary of Sinobiopharma. DongYing BVI is the sole shareholder of Big Global Limited, a company organized under the laws of Hong Kong, which in turn is the sole shareholder of DongYing (Jiangsu) Pharmaceuticals Co., Ltd. (“DongYing China”), a company organized under the laws of China. DongYing China is in the business of researching, producing and developing a variety of biopharmaceutical products, and has developed new methods for the synthesis of active pharmaceutical…